DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Death

 



Index of reports > Cases resulting in death (5)

     Guillain-Barre Syndrome (3)Muscle Spasms (3)Organ Failure (2)Cytomegalovirus Infection (2)Cardiovascular Disorder (2)Back Pain (1)Nausea (1)Hypotension (1)Pulmonary Oedema (1)Ventricular Fibrillation (1)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in death.

Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-02-20

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /; Diane



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a physician from Japan on 2007-02-05

Patient: male

Adverse reactions / side effects: Cardiovascular Disorder

Adverse event resulted in: death

Suspect drug(s):
Botox
    Dosage: unk, unk
    Indication: Torticollis
    Start date: 2004-12-01
    End date: 2004-12-01

Botox
    Start date: 2005-02-02
    End date: 2005-02-02

Botox
    Start date: 2005-04-06
    End date: 2005-04-06

Botox
    Start date: 2005-06-08
    End date: 2005-06-08

Botox
    Start date: 2005-08-24
    End date: 2005-08-24

Botox
    Start date: 2005-10-26
    End date: 2005-10-26

Other drugs received by patient: Alimemazine Tartrate; Sucralfate; Riboflavin TAB; Diastase; Dimeticone; Amlodipine Besylate; Benzbromarone; Propiverine Hydrochloride; Losartan Potassium; Nizatidine; Sennoside / 00571902 /



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a physician from Japan on 2007-01-29

Patient: male

Adverse reactions / side effects: Cardiovascular Disorder

Adverse event resulted in: death

Suspect drug(s):
Botox (Botulinum Toxin Type A)



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-01-23

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Guillain-Barre Syndrome, Cytomegalovirus Infection, Muscle Spasms, Organ Failure

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-01-16

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Death, Guillain-Barre Syndrome, Muscle Spasms

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009